AIHealthcare

AI-in-Healthcare Intelligence Platform

Quanterix

Healthcare / Life Sciences Tools Ultra-sensitive biomarker detection and digital immunoassays Public

Quanterix Corporation is a publicly traded life-sciences tools and diagnostics company that commercializes its Simoa (Single Molecule Array) platform for ultra-sensitive detection and measurement of proteins and other biomarkers. It positions the platform for research and healthcare use cases including biomarker discovery, clinical decision support, and precision medicine. While its biomarker-data capabilities may support AI-enabled healthcare workflows, the available sources characterize Quanterix primarily as a biomarker-detection and life-science-tools company rather than an AI-native healthcare company. The company trades on Nasdaq under the ticker QTRX and operates globally through direct operations, commercial partners, and distributors.

Company Details

Website
quanterix.com
Headquarters
Billerica, Massachusetts, United States
Founded
2007

Subscriber Intelligence

  • • Deal signal alerts for this company
  • • Sentiment & risk scoring
  • • Competitive framework analysis
  • • Regulatory event monitoring
← Back to Company Directory